News Articles

Press releases are listed below. Please click on a title to read the full text.

09/05/2001	Appointment of Finance Director
23/03/2001	Biocompatibles receives CE Mark Approval for its new BiodivYsio™ Small Vessel ("SV")
14/03/2001	Abbott Announces Pre-clinical Data on Drug Delivery Stent
09/03/2001	Preliminary Results for the Year Ended 31 December 2000
24/01/2001	Update on Stent Drug Delivery and Agreement with British Biotech and Abbott Laboratories
24/01/2001	Biocompatibles and British Biotech to Collaborate on Batimastat BiodivYsio Stent
01/11/2000	Companies Announcement Office
03/10/2000	Board Appointment
03/10/2000	PMA Approval for BiodivYsio Coronary Stent
12/09/2000	?Approvable? Notification Received from FDA for BiodivYsioTM Stent
12/09/2000	Interim Results for Six Months Ended 30 June 2000
06/07/2000	AGM Statement
22/05/2000	Positive Results of US Coronary Stent Clinical Trial and Update on US Product Approval Process
09/03/2000	Acquisition of Hydron Limited for ?38 million and Placing to Raise ?31 million
28/02/2000	BiodivYsio Stent Update
26/11/1999	BiodivYsio Drug Delivery Stent receives European Marketing Approval
22/11/1999	Agreement with Abbott Laboratories, Trading Update and Warrant Exercise Timetable
22/11/1999	Agreement with Abbott Laboratories for Vascular Products and PC Coating Technology
02/11/1999	Contact Lens Product Recall
26/09/1999	Placing and Open Offer

Showing 181-200 of 204 Page < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

In this section

Read detailed information about the business.